The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Parkinson Progression Marker Initiative (PPMI)
Open accessAbstract
The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational, international, multicenter study designed to identify PD progression biomarkers both to improve understanding of disease etiology and course and to provide crucial tools to enhance the likelihood of success of PD modifying therapeutic trials. The PPMI cohort will comprise 400 recently diagnosed PD and 200 healthy subjects followed longitudinally for clinical, imaging and biospecimen biomarker assessment using standardized data acquisition protocols at twenty-one clinical sites. All study data will be integrated in the PPMI study database and will be rapidly and publically available through the PPMI web site- www.ppmi-info.org. Biological samples including longitudinal collection of blood, cerebrospinal fluid (CSF) and urine will be available to scientists by application to an independent PPMI biospecimen review committee also through the PPMI web site. PPMI will rely on a partnership of government, PD foundations, industry and academics working cooperatively. This approach is crucial to enhance the potential for success of this ambitious strategy to develop PD progression biomarkers that will accelerate research in disease modifying therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationCerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Self-citationLevodopa and the Progression of Parkinson's Disease
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa033447 · Cited by 1,821
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
Olanow, C. W., Rascol, O., Hauser, R., Feigin, P. D., Jankovic, J., Lang, A., Langston, W., Melamed, E., Poewe, W., Stocchi, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809335 · Cited by 901
Self-citationSlower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
Whone, A. L., Watts, R. L., Stoessl, A. J., Davis, M., Reske, S., Nahmias, C., Lang, A. E., Rascol, O., Ribeiro, M. J., Remy, P., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10609 · Cited by 829
Self-citationEl‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715
The Alzheimer's Disease Neuroimaging Initiative: Progress report and future plans
Weiner, M. W., Aisen, P. S., Jack, C. R., Jagust, W. J., Trojanowski, J. Q., Shaw, L., Saykin, A. J., Morris, J. C., Cairns, N., Beckett, L. A., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.007 · Cited by 599
Self-citationThe parkinson's complex: Parkinsonism is just the tip of the iceberg
Langston, J. W. (2006) · Annals of Neurology · doi:10.1002/ana.20834 · Cited by 583
Research works printed but not linked: 3
- Jankovic, 1990, Lower body (vascular) parkinsonism, Arch. Neurol., 47, 728, 10.1001/archneur.1990.00530070014003 · doi:10.1001/archneur.1990.00530070014003
- The Lancet, 2010, Biomarker promise for Parkinson's disease, Lancet Neurol., 9, 1139, 10.1016/S1474-4422(10)70284-2 · doi:10.1016/s1474-4422(10)70284-2
- Vornov, 2006, GPI 1485, a neuroimmunophilin ligand, fails to alter disease progression in mild to moderate Parkinson's disease, Mov. Disord.
Cited by
VoxelMorph: A Learning Framework for Deformable Medical Image Registration
Balakrishnan, G., Zhao, A., Sabuncu, M. R., Guttag, J., & Dalca, A. V. (2019) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2897538 · Cited by 2,174
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
Irwin, D. J., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3549 · Cited by 869
Self-citationDiffusion models in medical imaging: A comprehensive survey
Kazerouni, A., Aghdam, E. K., Heidari, M., Azad, R., Fayyaz, M., Hacihaliloglu, I., & Merhof, D. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102846 · Cited by 765
Lead-DBS v2: Towards a comprehensive pipeline for deep brain stimulation imaging
Horn, A., Li, N., Dembek, T. A., Kappel, A., Boulay, C., Ewert, S., Tietze, A., Husch, A., Perera, T., Neumann, W.-J., et al. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2018.08.068 · Cited by 739
CSF and blood biomarkers for Parkinson's disease
Parnetti, L., Gaetani, L., Eusebi, P., Paciotti, S., Hansson, O., El-Agnaf, O., Mollenhauer, B., Blennow, K., & Calabresi, P. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30024-9 · Cited by 673
Self-citationThe Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort
Marek, K., Chowdhury, S., Siderowf, A., Lasch, S., Coffey, C. S., Caspell‐Garcia, C., Simuni, T., Jennings, D., Tanner, C. M., Trojanowski, J. Q., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.644 · Cited by 671
Self-citationSynthSeg: Segmentation of brain MRI scans of any contrast and resolution without retraining
Billot, B., Greve, D. N., Puonti, O., Thielscher, A., Van Leemput, K., Fischl, B., Dalca, A. V., & Iglesias, J. E. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102789 · Cited by 641
Fox, M. D., Buckner, R. L., Liu, H., Chakravarty, M. M., Lozano, A. M., & Pascual-Leone, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405003111 · Cited by 617
Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression
Fereshtehnejad, S.-M., Zeighami, Y., Dagher, A., & Postuma, R. B. (2017) · Brain · doi:10.1093/brain/awx118 · Cited by 613
An Unsupervised Learning Model for Deformable Medical Image Registration
Balakrishnan, G., Zhao, A., Sabuncu, M. R., Dalca, A. V., & Guttag, J. (2018) · 2018 IEEE/CVF Conference on Computer Vision and Pattern Recognition · doi:10.1109/cvpr.2018.00964 · Cited by 599
Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P., & Cheng, Y. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2742 · Cited by 554
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
Adler, C. H., Beach, T. G., Hentz, J. G., Shill, H. A., Caviness, J. N., Driver-Dunckley, E., Sabbagh, M. N., Sue, L. I., Jacobson, S. A., Belden, C. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000641 · Cited by 503
Self-citationTransformers in medical image analysis
He, K., Gan, C., Li, Z., Rekik, I., Yin, Z., Ji, W., Gao, Y., Wang, Q., Zhang, J., & Shen, D. (2023) · Intelligent Medicine · doi:10.1016/j.imed.2022.07.002 · Cited by 475
Unsupervised Learning of Probabilistic Diffeomorphic Registration for Images and Surfaces
Dalca, A. V., Balakrishnan, G., Guttag, J., & Sabuncu, M. R. (2019) · Medical Image Analysis · doi:10.1016/j.media.2019.07.006 · Cited by 467
Explainable Artificial Intelligence Applications in Cyber Security: State-of-the-Art in Research
Zhang, Z., Hamadi, H. A., Damiani, E., Yeun, C. Y., & Taher, F. (2022) · IEEE Access · doi:10.1109/access.2022.3204051 · Cited by 450
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Robak, L. A., Jansen, I. E., van Rooij, J., Uitterlinden, A. G., Kraaij, R., Jankovic, J., Heutink, P., Shulman, J. M., International Parkinson’s Disease Genomics Consortium (IPDGC), Nalls, M. A., et al. (2017) · Brain · doi:10.1093/brain/awx285 · Cited by 433
Self-citationData Augmentation Using Learned Transformations for One-Shot Medical Image Segmentation
Zhao, A., Balakrishnan, G., Durand, F., Guttag, J. V., & Dalca, A. V. (2019) · 2019 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) · doi:10.1109/cvpr.2019.00874 · Cited by 430
Schrag, A., Siddiqui, U. F., Anastasiou, Z., Weintraub, D., & Schott, J. M. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30328-3 · Cited by 425
Multimodal deep learning for Alzheimer's disease dementia assessment
Qiu, S., Miller, M. I., Joshi, P. S., Lee, J. C., Xue, C., Ni, Y., Wang, Y., De Anda-Duran, I., Hwang, P. H., Cramer, J. A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31037-5 · Cited by 420
Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature
Mei, J., Desrosiers, C., & Frasnelli, J. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.633752 · Cited by 401
Early Detection of Parkinson’s Disease Using Deep Learning and Machine Learning
Wang, W., Lee, J., Harrou, F., & Sun, Y. (2020) · IEEE Access · doi:10.1109/access.2020.3016062 · Cited by 397
Li, J., Chen, J., Tang, Y., Wang, C., Landman, B. A., & Zhou, S. K. (2023) · Medical Image Analysis · doi:10.1016/j.media.2023.102762 · Cited by 389
Quantitative wearable sensors for objective assessment of Parkinson's disease
Maetzler, W., Domingos, J., Srulijes, K., Ferreira, J. J., & Bloem, B. R. (2013) · Movement Disorders · doi:10.1002/mds.25628 · Cited by 374
Kang, J.-H. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3861 · Cited by 367
Biomarkers of Parkinson’s disease: Present and future
Miller, D. B., & O’Callaghan, J. P. (2015) · Metabolism · doi:10.1016/j.metabol.2014.10.030 · Cited by 358
Age at onset and Parkinson disease phenotype
Pagano, G., Ferrara, N., Brooks, D. J., & Pavese, N. (2016) · Neurology · doi:10.1212/wnl.0000000000002461 · Cited by 358
Self-citationUnsupervised Learning for Fast Probabilistic Diffeomorphic Registration
Dalca, A. V., Balakrishnan, G., Guttag, J., & Sabuncu, M. R. (2018) · Lecture Notes in Computer Science · doi:10.1007/978-3-030-00928-1_82 · Cited by 354
Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease
De Pablo-Fernández, E., Lees, A. J., Holton, J. L., & Warner, T. T. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4377 · Cited by 332
Using Digital Health Technology to Better Generate Evidence and Deliver Evidence-Based Care
Sharma, A., Harrington, R. A., McClellan, M. B., Turakhia, M. P., Eapen, Z. J., Steinhubl, S., Mault, J. R., Majmudar, M. D., Roessig, L., Chandross, K. J., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.03.523 · Cited by 332
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease
Weintraub, D., Simuni, T., Caspell‐Garcia, C., Coffey, C., Lasch, S., Siderowf, A., Aarsland, D., Barone, P., Burn, D., Chahine, L. M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26170 · Cited by 305
Self-citationMagesh, P. R., Myloth, R. D., & Tom, R. J. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104041 · Cited by 295
Yang, C., Farias, F. H. G., Ibanez, L., Suhy, A., Sadler, B., Fernandez, M. V., Wang, F., Bradley, J. L., Eiffert, B., Bahena, J. A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00886-6 · Cited by 290
The Concept of Prodromal Parkinson’s Disease
Mahlknecht, P., Seppi, K., & Poewe, W. (2015) · Journal of Parkinson's Disease · doi:10.3233/jpd-150685 · Cited by 288
Self-citationDeep learning based diagnosis of Parkinson’s disease using convolutional neural network
Sivaranjini, S., & Sujatha, C. M. (2020) · Multimedia Tools and Applications · doi:10.1007/s11042-019-7469-8 · Cited by 281
The vermiform appendix impacts the risk of developing Parkinson’s disease
Killinger, B. A., Madaj, Z., Sikora, J. W., Rey, N., Haas, A. J., Vepa, Y., Lindqvist, D., Chen, H., Thomas, P. M., Brundin, P., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar5280 · Cited by 279
Morbelli, S., Esposito, G., Arbizu, J., Barthel, H., Boellaard, R., Bohnen, N. I., Brooks, D. J., Darcourt, J., Dickson, J. C., Douglas, D., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04817-8 · Cited by 273
Self-citationGraph-Based Deep Learning for Medical Diagnosis and Analysis: Past, Present and Future
Ahmedt-Aristizabal, D., Armin, M. A., Denman, S., Fookes, C., & Petersson, L. (2021) · Sensors · doi:10.3390/s21144758 · Cited by 272
Network connectivity determines cortical thinning in early Parkinson’s disease progression
Yau, Y., Zeighami, Y., Baker, T. E., Larcher, K., Vainik, U., Dadar, M., Fonov, V. S., Hagmann, P., Griffa, A., Mišić, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02416-0 · Cited by 270
BRAPH: A graph theory software for the analysis of brain connectivity
Mijalkov, M., Kakaei, E., Pereira, J. B., Westman, E., Volpe, G., & Initiative, F. T. A. D. N. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178798 · Cited by 256
Prashanth, R., Dutta Roy, S., Mandal, P. K., & Ghosh, S. (2016) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2016.03.001 · Cited by 244
Si, Y., Du, J., Li, Z., Jiang, X., Miller, T., Wang, F., Jim Zheng, W., & Roberts, K. (2021) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103671 · Cited by 235
BrainGB: A Benchmark for Brain Network Analysis with Graph Neural Networks
Cui, H., Dai, W., Zhu, Y., Kan, X., Gu, A. A. C., Lukemire, J., Zhan, L., He, L., Guo, Y., & Yang, C. (2023) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2022.3218745 · Cited by 218
“For the HIV and PPMI datasets, the task is to classify patients from healthy control (Patient, Normal Control); while for the PNC and ABCD datasets, the task is gender prediction (Male, Female).”
InfluentialCerebrospinal fluid biomarkers in Parkinson disease
Parnetti, L., Castrioto, A., Chiasserini, D., Persichetti, E., Tambasco, N., El-Agnaf, O., & Calabresi, P. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.10 · Cited by 209
UniverSeg: Universal Medical Image Segmentation
Butoi, V. I., Gonzalez Ortiz, J. J., Ma, T., Sabuncu, M. R., Guttag, J., & Dalca, A. V. (2023) · 2023 IEEE/CVF International Conference on Computer Vision (ICCV) · doi:10.1109/iccv51070.2023.01960 · Cited by 195
Opportunities of connectomic neuromodulation
Horn, A., & Fox, M. D. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117180 · Cited by 187
Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease
Silva de Lima, A. L., Hahn, T., Evers, L. J. W., de Vries, N. M., Cohen, E., Afek, M., Bataille, L., Daeschler, M., Claes, K., Boroojerdi, B., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189161 · Cited by 162
“All enrolled participants received a single medical examination, based on the “Parkinson’s Progression Markers Initiative” (PPMI)[21].”
Computer-Aided diagnosis of Parkinson’s Disease Using Enhanced Probabilistic Neural Network
Hirschauer, T. J., Adeli, H., & Buford, J. A. (2015) · Journal of Medical Systems · doi:10.1007/s10916-015-0353-9 · Cited by 177
APOE genotype regulates pathology and disease progression in synucleinopathy
Davis, A. A., Inman, C. E., Wargel, Z. M., Dube, U., Freeberg, B. M., Galluppi, A., Haines, J. N., Dhavale, D. D., Miller, R., Choudhury, F. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay3069 · Cited by 177
AI-based differential diagnosis of dementia etiologies on multimodal data
Xue, C., Kowshik, S. S., Lteif, D., Puducheri, S., Jasodanand, V. H., Zhou, O. T., Walia, A. S., Guney, O. B., Zhang, J. D., Poésy, S., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03118-z · Cited by 182
Data-driven subtyping of Parkinson's disease using longitudinal clinical records: a cohort study
Zhang, X., Chou, J., Liang, J., Xiao, C., Zhao, Y., Sarva, H., Henchcliffe, C., & Wang, F. (2019) · Scientific Reports · doi:10.1038/s41598-018-37545-z · Cited by 137
Liu, G., Peng, J., Liao, Z., Locascio, J. J., Corvol, J.-C., Zhu, F., Dong, X., Maple-Grødem, J., Campbell, M. C., Elbaz, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00847-6 · Cited by 127
Self-citationDetect and correct bias in multi-site neuroimaging datasets
Wachinger, C., Rieckmann, A., & Pölsterl, S. (2021) · Medical Image Analysis · doi:10.1016/j.media.2020.101879 · Cited by 115
Dentamaro, V., Impedovo, D., Musti, L., Pirlo, G., & Taurisano, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-70165-4 · Cited by 116
Veitch, D. P., Weiner, M. W., Miller, M., Aisen, P. S., Ashford, M. A., Beckett, L. A., Green, R. C., Harvey, D., Jack, C. R., Jagust, W., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13449 · Cited by 113
Self-citationRamos, D. M., Skarnes, W. C., Singleton, A. B., Cookson, M. R., & Ward, M. E. (2021) · Neuron · doi:10.1016/j.neuron.2021.03.022 · Cited by 107
Self-citationDeep Learning in Medical Image Registration
Chen, X., Diaz-Pinto, A., Ravikumar, N., & Frangi, A. (2020) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/abd37c · Cited by 106
Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
Adams, J. L., Kangarloo, T., Tracey, B., O’Donnell, P., Volfson, D., Latzman, R. D., Zach, N., Alexander, R., Bergethon, P., Cosman, J., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00497-x · Cited by 98
Self-citationTMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia
Tropea, T. F., Mak, J., Guo, M. H., Xie, S. X., Suh, E., Rick, J., Siderowf, A., Weintraub, D., Grossman, M., Irwin, D., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25486 · Cited by 83
Self-citationA review of deep learning-based deformable medical image registration
Zou, J., Gao, B., Song, Y., & Qin, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1047215 · Cited by 126
“PPMI (31) MRI Brain 3D 423 2011 PD Identify biomarkers of PD progression”
BackgroundZhang, F., Wu, Y., Norton, I., Rathi, Y., Golby, A. J., & O'Donnell, L. J. (2019) · Human Brain Mapping · doi:10.1002/hbm.24579 · Cited by 89
A review of deep learning-based three-dimensional medical image registration methods
Xiao, H., Teng, X., Liu, C., Li, T., Ren, G., Yang, R., Shen, D., & Cai, J. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-21-175 · Cited by 77
Large-Scale Wearable Sensor Deployment in Parkinson’s Patients: The Parkinson@Home Study Protocol
Silva de Lima, A. L., Hahn, T., de Vries, N. M., Cohen, E., Bataille, L., Little, M. A., Baldus, H., Bloem, B. R., & Faber, M. J. (2016) · JMIR Research Protocols · doi:10.2196/resprot.5990 · Cited by 63
Brumm, M. C., Siderowf, A., Simuni, T., Burghardt, E., Choi, S. H., Caspell-Garcia, C., Chahine, L. M., Mollenhauer, B., Foroud, T., Galasko, D., et al. (2023) · Journal of Parkinson’s Disease · doi:10.3233/jpd-223433 · Cited by 70
Self-citationA proteogenomic view of Parkinson’s disease causality and heterogeneity
Kaiser, S., Zhang, L., Mollenhauer, B., Jacob, J., Longerich, S., Del-Aguila, J., Marcus, J., Raghavan, N., Stone, D., Fagboyegun, O., et al. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-023-00461-9 · Cited by 68
Self-citationSerotonin, β‐amyloid, and cognition in Parkinson disease
Kotagal, V., Spino, C., Bohnen, N. I., Koeppe, R., & Albin, R. L. (2018) · Annals of Neurology · doi:10.1002/ana.25236 · Cited by 64
Toffoli, M., Chen, X., Sedlazeck, F. J., Lee, C.-Y., Mullin, S., Higgins, A., Koletsi, S., Garcia-Segura, M. E., Sammler, E., Scholz, S. W., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03610-7 · Cited by 59
“These included 15 samples from 1kGP with CNVs or gene conversions, and 22 samples from Parkinson ’ s Progression Markers Initiative (PPMI — included in AMP-PD cohort), where Gauchian showed CNVs or GBAP1 -related variants ( n = 7), or was discordant with available Broad Institute ’ s Joint Genotyping pipeline (referre…”
Yang, C., Fagan, A. M., Perrin, R. J., Rhinn, H., Harari, O., & Cruchaga, C. (2022) · Genome Medicine · doi:10.1186/s13073-022-01140-9 · Cited by 53
Effects of MRI scanner manufacturers in classification tasks with deep learning models
Kushol, R., Parnianpour, P., Wilman, A. H., Kalra, S., & Yang, Y.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-43715-5 · Cited by 54
“Notably, in the PPMI dataset, using data from Siemens and GE also yields an average accuracy of around 90%, while using Philips data results in an approximate classification accuracy of 85%.”
InfluentialDopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
Hinkle, J. T., Perepezko, K., Mills, K. A., Mari, Z., Butala, A., Dawson, T. M., Pantelyat, A., Rosenthal, L. S., & Pontone, G. M. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.010 · Cited by 49
Self-citationStephenson, D., Hill, D., Cedarbaum, J. M., Tome, M., Vamvakas, S., Romero, K., Conrado, D. J., Dexter, D. T., Seibyl, J., Jennings, D., et al. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191648 · Cited by 46
Self-citationPrivacy-Net: An Adversarial Approach for Identity-Obfuscated Segmentation of Medical Images
Kim, B. N., Dolz, J., Jodoin, P.-M., & Desrosiers, C. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3065727 · Cited by 43
Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration
Staffaroni, A. M., Cobigo, Y., Goh, S. M., Kornak, J., Bajorek, L., Chiang, K., Appleby, B., Bove, J., Bordelon, Y., Brannelly, P., et al. (2020) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2019.04.007 · Cited by 40
Self-citationLaFlamme, C. W., Rastin, C., Sengupta, S., Pennington, H. E., Russ-Hall, S. J., Schneider, A. L., Bonkowski, E. S., Almanza Fuerte, E. P., Allan, T. J., Zalusky, M. P.-G., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50159-6 · Cited by 31
Ostertag, C., Visani, M., Urruty, T., & Beurton-Aimar, M. (2023) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-023-02866-6 · Cited by 26
Exploring the link between GBA1 mutations and Dementia with Lewy bodies, A mini-review
Gaubert, S., Hourregue, C., Mouton-Liger, F., Millot, P., Franco, M., Amar-Bouaziz, E., Aarsland, D., Hugon, J., & Paquet, C. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104856 · Cited by 26
Genome-wide determinants of mortality and motor progression in Parkinson’s disease
Tan, M. M. X., Lawton, M. A., Pollard, M. I., Brown, E., Real, R., Carrasco, A. M., Bekadar, S., Jabbari, E., Reynolds, R. H., Iwaki, H., et al. (2024) · npj Parkinson's Disease · doi:10.1038/s41531-024-00729-8 · Cited by 17
Self-citationMulti-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease
Loo, R. T. J., Pavelka, L., Mangone, G., Khoury, F., Vidailhet, M., Corvol, J.-C., Glaab, E., On behalf of the NCER-PD Consortium, Acharya, G., Aguayo, G., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01862-1 · Cited by 9
“To address this, this study integrates clinical data from three independent cohorts (the Luxembourgish Parkinson ’ s Study (LUXPARK) 27 , the Parkinson ’ s Pro-gressionMarkersInitiative(PPMI) 28 ,andtheFrenchcohortICEBERG 29 )to identify more robust and generalizable predictors of CI in PD.”
Self-citationA genetic and proteomic comparison of key AD biomarkers across tissues
Marsh, T. W., Western, D., Timsina, J., Gorijala, P., Yang, C., Pastor, P., Liu, M., Morris, J. C., Bateman, R. J., Schindler, S. E., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.14139 · Cited by 6
Portable objective assessment of upper extremity motor function in Parkinson's disease
Chahine, L. M., Uribe, L., Hogarth, P., McNames, J., Siderowf, A., Marek, K., & Jennings, D. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.017 · Cited by 4
Self-citationStudy of blood linear RNA nominates CD55 and DLD as early-stage biomarkers for Parkinson's disease
Beric, A., Sahin, S., Sanchez, S., Yang, Z., Kumar, R., Alfradique-Dunham, I., Sanford, J., Western, D., Phillips, B., Budde, J. P., et al. (2026) · Brain · doi:10.1093/brain/awag014 · Cited by 2
Metadata
- Authors
- Marek, K., Jennings, D., Lasch, S., Siderowf, A., Tanner, C., Simuni, T., Coffey, C., Kieburtz, K., Flagg, E., Chowdhury, S., Poewe, W., Mollenhauer, B., Klinik, P.-E., Sherer, T., Frasier, M., Meunier, C., Rudolph, A., Casaceli, C., Seibyl, J., Mendick, S., Schuff, N., Zhang, Y., Toga, A., Crawford, K., Ansbach, A., De Blasio, P., Piovella, M., Trojanowski, J., Shaw, L., Singleton, A., Hawkins, K., Eberling, J., Brooks, D., Russell, D., Leary, L., Factor, S., Sommerfeld, B., Hogarth, P., Pighetti, E., Williams, K., Standaert, D., Guthrie, S., Hauser, R., Delgado, H., Jankovic, J., Hunter, C., Stern, M., Tran, B., Leverenz, J., Baca, M., Frank, S., Thomas, C.-A., Richard, I., Deeley, C., Rees, L., Sprenger, F., Lang, E., Shill, H., Obradov, S., Fernandez, H., Winters, A., Berg, D., Gauss, K., Galasko, D., Fontaine, D., Mari, Z., Gerstenhaber, M., Brooks, D., Malloy, S., Barone, P., Longo, K., Comery, T., Ravina, B., Grachev, I., Gallagher, K., Collins, M., Widnell, K. L., Ostrowizki, S., Fontoura, P., Ho, T., Luthman, J., Brug, M. V. D., Reith, A. D., & Taylor, P.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 95
- Issue
- 4
- Pages
- 629-635
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1988494453
- Cited by
- 1,892
- References
- 40
- FWCI
- 15.73
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.